Sharon Reif1, Andrea Acevedo1, Deborah W Garnick1, Catherine A Fullerton1. 1. Dr. Reif, Dr. Acevedo, and Dr. Garnick are with the Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts. Dr. Acevedo is also with the Department of Community Health, Tufts University, Medford, Massachusetts. At the time of the study, Dr. Fullerton was with Truven Health Analytics, Cambridge, Massachusetts.
Abstract
OBJECTIVE: Individuals with substance use disorders are at high risk of hospital readmission. This study examined whether follow-up services received within 14 days of discharge from an inpatient hospital stay or residential detoxification reduced 90-day readmissions among Medicaid enrollees whose index admission included a substance use disorder diagnosis. METHODS: Claims data were analyzed for Medicaid enrollees ages 18-64 with a substance use disorder diagnosis coded in any position for an inpatient hospital stay or residential detoxification in 2008 (N=30,439). Follow-up behavioral health services included residential, intensive outpatient, outpatient, and medication-assisted treatment (MAT). Analyses included data from ten states or fewer, based on a minimum number of index admissions and the availability of follow-up services or MAT. Survival analyses with time-varying independent variables were used to test the association of receipt of follow-up services and MAT with behavioral health readmissions. RESULTS: Two-thirds (67.7%) of these enrollees received no follow-up services within 14 days. Twenty-nine percent were admitted with a primary behavioral health diagnosis within 90 days of discharge. Survival analyses showed that MAT and residential treatment were associated with reduced risk of 90-day behavioral health admission. Receipt of outpatient treatment was associated with increased readmission risk, and, in only one model, receipt of intensive outpatient services was also associated with increased risk. CONCLUSIONS: Provision of MAT or residential treatment for substance use disorders after an inpatient or detoxification stay may help prevent readmissions. Medicaid programs should be encouraged to reduce barriers to MAT and residential treatment in order to prevent behavioral health admissions.
OBJECTIVE: Individuals with substance use disorders are at high risk of hospital readmission. This study examined whether follow-up services received within 14 days of discharge from an inpatient hospital stay or residential detoxification reduced 90-day readmissions among Medicaid enrollees whose index admission included a substance use disorder diagnosis. METHODS: Claims data were analyzed for Medicaid enrollees ages 18-64 with a substance use disorder diagnosis coded in any position for an inpatient hospital stay or residential detoxification in 2008 (N=30,439). Follow-up behavioral health services included residential, intensive outpatient, outpatient, and medication-assisted treatment (MAT). Analyses included data from ten states or fewer, based on a minimum number of index admissions and the availability of follow-up services or MAT. Survival analyses with time-varying independent variables were used to test the association of receipt of follow-up services and MAT with behavioral health readmissions. RESULTS: Two-thirds (67.7%) of these enrollees received no follow-up services within 14 days. Twenty-nine percent were admitted with a primary behavioral health diagnosis within 90 days of discharge. Survival analyses showed that MAT and residential treatment were associated with reduced risk of 90-day behavioral health admission. Receipt of outpatient treatment was associated with increased readmission risk, and, in only one model, receipt of intensive outpatient services was also associated with increased risk. CONCLUSIONS: Provision of MAT or residential treatment for substance use disorders after an inpatient or detoxification stay may help prevent readmissions. Medicaid programs should be encouraged to reduce barriers to MAT and residential treatment in order to prevent behavioral health admissions.
Authors: Amy K Rosen; Qi Chen; Marlena H Shin; William O'Brien; Michael Shwartz; Hillary J Mull; Marisa Cevasco; Ann M Borzecki Journal: Med Care Date: 2014-03 Impact factor: 2.983
Authors: Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds Journal: J Subst Abuse Treat Date: 2014-05-02
Authors: Catherine Anne Fullerton; Meelee Kim; Cindy Parks Thomas; D Russell Lyman; Leslie B Montejano; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Miriam E Delphin-Rittmon Journal: Psychiatr Serv Date: 2014-02-01 Impact factor: 3.084
Authors: Alexander Y Walley; Sara Lodi; Yijing Li; Dana Bernson; Hermik Babakhanlou-Chase; Thomas Land; Marc R Larochelle Journal: Addiction Date: 2020-02-25 Impact factor: 6.526
Authors: Katherine Mackey; Stephanie Veazie; Johanna Anderson; Donald Bourne; Kim Peterson Journal: J Gen Intern Med Date: 2020-11-03 Impact factor: 5.128
Authors: Deborah W Garnick; Constance M Horgan; Andrea Acevedo; Margaret T Lee; Lee Panas; Grant A Ritter; Kevin Campbell Journal: J Rural Health Date: 2019-05-15 Impact factor: 4.333
Authors: Robert W Kirchoff; Norhan M Mohammed; Jack McHugh; Matej Markota; Thomas Kingsley; Jonathan Leung; M Caroline Burton; Rahul Chaudhary Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-04-08
Authors: Payel J Roy; Ryan Price; Sugy Choi; Zoe M Weinstein; Edward Bernstein; Chinazo O Cunningham; Alexander Y Walley Journal: Drug Alcohol Depend Date: 2021-04-20 Impact factor: 4.852